ETHNOPHARMACOLOGICAL RELEVANCE:In traditional Chinese medicine (TCM), diabetes falls under the category of "wasting-and-thirst disease". Polygonatum odoratum (Mill.) Druce, a medicinal herb from the Liliaceae family, is renowned for its ability to nourish yin, alleviate dryness, promote fluid production, and relieve thirst. Its efficacy in addressing yin deficiency with internal heat and fluid depletion makes it a promising candidate for diabetes management. Among its bioactive compounds, Polygonatum odoratum (Mill.) Druce polysaccharides (POPs) play a crucial role in yin nourishment and blood sugar regulation. However, the incomplete structural characterization of these polysaccharides remains a major obstacle in advancing POPs research. Furthermore, studies on POPs' therapeutic mechanisms in hyperglycemia are still lacking.
PURPOSE:This study isolated a neutral polysaccharide (POP1) from Polygonatum odoratum (Mill.) Druce and investigated its primary and higher-order structural features. Additionally, we investigated the protective effect of POP1 in a hyperglycemic mouse model and explored the underlying mechanisms.
METHODS:The crude POP was prepared by hot water extraction and alcohol precipitation. Then, it was separated and purified by Diethylaminoethyl (DEAE)-52 ion exchange chromatography and Sephadex G-100 gel filtration technology respectively to obtain the main fraction, named POP1. POP1 was characterized in terms of molecular weight, primary structure, and higher-order structure by high-performance liquid chromatography (HPLC), fourier transform infrared (FT-IR) spectroscopy, nuclear magnetic resonance (NMR), scanning electron microscopy (SEM), and atomic force microscopy (AFM). A hyperglycemic mouse model was established by the long-term feeding of a high-fat diet (HFD) combined with streptozotocin (STZ). The potential mechanism of POP1 in improving hyperglycemia was evaluated by histopathological staining, immunofluorescence staining, western blotting, and Enzyme-linked immunosorbent assay (ELISA).
RESULTS:Our findings demonstrated that POP1 primarily consists of glucose and mannose, interconnected by five distinct glycosidic bonds: →1)-β-D-Fruf-(2→, →6)-β-D-Fruf-(2→, →1,6)-β-D-Fruf-(2→, β-D-Fruf-(2→, and α-D-Man. Oral administration of POP1 significantly ameliorated HFD/STZ-induced hyperglycemia. The hypoglycemic effect was attributed to POP1's activation of the phosphatidylinositol 3 kinase (PI3K)-protein kinase B (Akt)-glycogen synthase kinase 3β (GSK3β)/Recombinant Forkhead Box Protein O1 (FoxO1) signaling pathway, which enhanced hepatic glycogen synthesis while suppressing glycogen breakdown, thereby reducing blood glucose levels. From the perspective of structural research, it is speculated that β-fructofuranose residues and specific glycosidic bonds (such as 1 → 6) are the key structural elements for POP1 to exert significant hypoglycemic activity. Moreover, POP1 has a smooth surface, and the polysaccharide molecules may intertwine with each other through their branched chains in aqueous solution to form a large conical aggregate, which may be the reason for its improved bioactivity.
CONCLUSIONS:The hypoglycemic mechanism of POP1 may involve the regulation of insulin-mediated glycogen synthesis and gluconeogenesis. Its primary structure (β-fructofuranose residues, 1 → 6 glycosidic bonds) and higher-order structure (branched chains winding to form conical aggregates) are likely key to its hypoglycemic activity. In conclusion, this study demonstrated that POP1 could be a promising functional food or pharmaceutical supplements to improve symptoms of hyperglycemia.
